triiodothyronine has been researched along with Inflammatory Bowel Diseases in 5 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 4 (80.00) | 2.80 |
Authors | Studies |
---|---|
Bertani, L | 3 |
Tricò, D | 3 |
Pugliese, D | 2 |
Privitera, G | 1 |
Linsalata, G | 1 |
Zanzi, F | 1 |
Gloria Mumolo, M | 1 |
Barberio, B | 1 |
Monzani, F | 1 |
Marchi, S | 1 |
Guidi, L | 1 |
Blandizzi, C | 2 |
Armuzzi, A | 1 |
Costa, F | 2 |
Carbery, I | 1 |
Selinger, CP | 1 |
Paschou, SA | 1 |
Palioura, E | 1 |
Kothonas, F | 1 |
Myroforidis, A | 1 |
Loi, V | 1 |
Poulou, A | 1 |
Goumas, K | 1 |
Effraimidis, G | 1 |
Vryonidou, A | 1 |
5 other studies available for triiodothyronine and Inflammatory Bowel Diseases
Article | Year |
---|---|
Editorial: serum triiodothyronine-to-thyroxine (T3/T4) ratio as biomarker of response in IBD - an open issue.
Topics: Biomarkers; Humans; Inflammatory Bowel Diseases; Thyroxine; Triiodothyronine | 2022 |
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients.
Topics: Aged; Biological Therapy; Humans; Inflammatory Bowel Diseases; Middle Aged; Thyroxine; Treatment Out | 2021 |
Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD? Authors' reply.
Topics: Aged; Biological Products; Biological Therapy; Humans; Inflammatory Bowel Diseases; Thyroxine; Treat | 2021 |
Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD?
Topics: Aged; Biological Products; Biological Therapy; Humans; Inflammatory Bowel Diseases; Thyroxine; Treat | 2021 |
The effect of anti-TNF therapy on thyroid function in patients with inflammatory bowel disease.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Female; Gastrointestinal A | 2018 |